News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients
Photo: Pat Garcia-Gonzalez/ LinkedIn
May 17, 2023, 16:39

BeiGene, Max Foundation team up to provide free Brukinsa to CLL patients

Grateful today for our new partnership with BeiGene and the opportunity to help people living with CLL access treatment. –Pat Garcia-Gonzalez

Source: Pat Garcia-Gonzalez/ LinkedIn

 

BeiGene Brukinsa Max Foundation
Special Coverage
Blog
Apr 24, 2025, 17:06
Mohamad Mohty: Welcome to ⁦the World Congress on Controversies in Multiple Myeloma
Science
Apr 24, 2025, 16:57
Clinical Impact of SVGs of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced NSCLC
Blog
Apr 24, 2025, 16:56
SIOP 2025 Keynote Sessions to address global challenges and advances in paediatric oncology
Blog
Apr 24, 2025, 16:34
Use of Buprenorphine for the treatment of central pain - MASCC
Blog
Apr 24, 2025, 16:30
Karine Tawagi: GU abstracts for ASCO25
Blog
Apr 24, 2025, 16:20
Raffaele Colombo: Honored to be speaking at AACR25 educational session on next generation ADCs
Blog
Apr 24, 2025, 16:13
Recognizing our outstanding cancer research trainee - UF Health Cancer Center Cancer Training and Education Program
Blog
Apr 24, 2025, 16:05
Maximilian Stahl returns to Yale to lead Leukemia Program - Yale Cancer Center
Blog
Apr 24, 2025, 15:49
Heading to Chicago for the 2025 AACR Annual Meeting - Yale Cancer Center
Blog
Apr 24, 2025, 15:39
Tsetsegsaikhan Batmunkh: First Country in WHO WPRO to Implement Global Platform for Childhood Cancer Medicines
Blog
Apr 24, 2025, 15:09
Daniel Starczynowski: Microbial metabolite drives ageing-related clonal hematopoiesis via ALPK1
Science
Apr 24, 2025, 14:49
Feasibility, reliability and validity of smartphone administered cognitive ecological momentary assessments in breast cancer survivors